Issue 6, 2012

Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)

Abstract

Potent ROCK inhibitors of a new class of 1-benzyl-3-(4-pyridylthiazol-2-yl)ureas have been identified. Remarkable differences in activity were observed for ureas bearing a benzylic stereogenic center. Derivatives with hydroxy, methoxy and amino groups at the meta position of the phenyl ring give rise to the most potent inhibitors (low nM). Substitutions at the para position result in substantial loss of potency. Changes at the benzylic position are tolerated resulting in significant potency in the case of methyl and methylenehydroxy groups. X-Ray crystallography was used to establish the binding mode of this class of inhibitors and provides an explanation for the observed differences of the enantiomer series. Potent inhibition of ROCK in human lung cancer cells was shown by suppression of the levels of phosphorylation of the ROCK substrate MYPT-1.

Graphical abstract: Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)

Supplementary files

Article information

Article type
Concise Article
Submitted
30 Dec 2011
Accepted
25 Jan 2012
First published
27 Jan 2012

Med. Chem. Commun., 2012,3, 699-709

Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)

R. Pireddu, K. D. Forinash, N. N. Sun, M. P. Martin, S. Sung, B. Alexander, J. Zhu, W. C. Guida, E. Schönbrunn, S. M. Sebti and N. J. Lawrence, Med. Chem. Commun., 2012, 3, 699 DOI: 10.1039/C2MD00320A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements